• A-
  • A
  • A+

Dr. Daniel Sterman

Dr. Daniel Sterman is optimistic about the future of pleural mesothelioma treatment. In a recent speech on the topic, Sterman said the advances in early detection, surgical procedures and curative therapies show that medical science is working toward advanced treatment options.

Sterman is the University of Pennsylvania’s director of interventional pulmonary services and co-director of the university’s mesothelioma and pleural disease program. He’s also an associate professor at the university’s hospital and the Presbyterian Medical Center of Philadelphia.

Connect with Top Doctors and Cancer Centers

Get help connecting with a mesothelioma doctor or treatment center near you right now!

Mesothelioma Specialist in Pennsylvania

Dozens of sites throughout Pennsylvania have been identified as having deadly asbestos. This includes common industries in the state including shipyards, oil refineries, power plans and steel mills. Many public buildings, especially those constructed before 1980, are known to have asbestos in the walls, floors and ceilings. There are also several naturally occurring asbestos deposits in the less-rural areas.

There are several mesothelioma specialists in Pennsylvania. Anyone who has been diagnosed with the disease should seek out one of these professionals for the best possible care. Contact us today for information about getting a quick appointment with a skilled mesothelioma specialist.

What are Sterman’s specialties

Early in his career, Sterman specialized in critical care. When he turned his attention to thoracic oncology he also became interested in genetic immunotherapy. He considers it an alternative cancer treatment that has promising results. Sterman is continually using novel advanced techniques to battle thoracic cancers. These include pleuroscopy, endobronchial stent placement and endobronchial brachytherapy.

Sterman’s research expertise focuses on thoracic cancers with an interest in interventional diagnostic and therapeutic techniques for mesothelioma, lung cancer and other thoracic cancers. He has a special interest in gene therapy, tumor immunology and tumor vaccines.

Sterman is a highly sought after speaker on the topic of thoracic malignancies. He is an advocate for an easy and painless test for an early mesothelioma diagnosis. Although researchers are not there yet, he said they are continually working on it.

What is Sterman’s background

Sterman graduated from Cornell University Medical School in 1989 and went on to complete internships and his residency at the Hospital of the University of Pennsylvania. He also completed his fellowship training at the hospital in several fields including pulmonary and critical care medicine, interventional bronchoscopy and thoracic oncology.

Sterman’s research work includes studies in mesothelioma including “A phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusions.” Other research looks at lung and thoracic cancers.

Sterman is continually receiving accolades from peers and medical associations. He has been recognized by America’s Top Doctors, Best Doctors in America and Philadelphia Magazine for excellence. He received the National Institutes of Health Associate Physician Award.


Abramson Cancer Center. Daniel H. Sterman, MD. Retrieved from http://www.penncancer.org/patients/find-a-doctor/313/

Penn Medicine. Daniel Sterman, MD. Retrieved from http://www.pennmedicine.org/providers/profile/daniel-sterman